Skip to content

In Europe, Sun Pharma has always had a focus on developing and offering hospital products in oncology and other areas.
Since the acquisition of Ranbaxy in 2015, a portfolio of retail products was added.
For the European hospital market, Sun aims to develop iv products that are convenient to use, such as Ready-to-Administer products in bags and syringes.
The first result of this initiative is launched in 2016.

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.